Distinct Non-Human Leukocyte Antigen Antibody Signatures Correlate with Endothelial Crossmatch Status in Lung and Renal Transplant Recipients
Authors:
- Fahd AlhamdanFAFahd Alhamdan
- Antonio CoppolinoACAntonio Coppolino
- Adil SheikhASAdil Sheikh
- Anna MieleAMAnna Miele
- Stefi LeeSLStefi Lee
- Allison GasiewskiAGAllison Gasiewski
- Peter BresciaPBPeter Brescia
- Isabelle WoodIWIsabelle Wood
- Arvin VenkatAVArvin Venkat
- Tany ThaniyavarnTTTany Thaniyavarn
- Selvin JacobSJSelvin Jacob
- Mohamed KeshkMKMohamed Keshk
Open Access
- 30 September 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (19) , 10562
Abstract
Non-HLA antibodies against heterogeneous targets on endothelial cells have been associated with allograft injuries. The endothelial cell crossmatch (ECXM) is used in the detection of non-HLA antibodies but remains non-discriminatory for specific antibody identification. The primary objective of this study was to delineate the specific non-HLA antibody signatures associated with ECXM positivity and to determine the correlation of ECXM status and non-HLA antibody signatures on allograft health. Serum specimens from 25 lung transplant recipients (LTRs) and 13 renal transplant recipients (RTRs) were collected as part of clinical evaluation, and testing for angiotensin II receptor type 1 (AT1R) and donor-specific MHC class I chain-related gene A (MICA) antibodies and ECXM was performed. Remnant sera were tested for non-HLA antibodies using the LABScreen™ Autoantibody (LSAUT) Group 1, 2, and 3 kits (One Lambda, Inc., Los Angeles, CA, USA). In both cohorts, the concordance of AT1R and MICA together or individually with ECXM+ status was poor (<0.7), suggesting the presence of other unaccounted antibodies. Autoantibody profiling revealed three distinct clusters targeting fibrotic products, cytoskeletal proteins, and cell signaling molecules. A comparative analysis of ECXM+ and ECXM− specimens identified nine and five differentially expressed antibodies in the LTR and RTR cohorts, respectively. Employing machine learning techniques (variable importance, feature selection, ROC-AUC), we derived a five-antibody panel (TNFα, collagen V, CXCL11, GDNF, GAPDH) and a two-antibody panel (TNFα, CXCL9) that effectively discriminated between ECXM+ and ECXM− status in the LTR and RTR cohorts, respectively. Distinct antibody signatures were identified in LTR and RTR cohorts that correlated with ECXM+ status and were associated with allograft dysfunction.Keywords
Funding Information
- NIH (1R01HL161620)
This publication has 44 references indexed in Scilit:
- Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung TransplantationThe Journal of Heart and Lung Transplantation, 2021
- Regulation of endothelial cell survival and death by the MAP kinase/ERK kinase kinase 3 - glyceraldehyde-3-phosphate dehydrogenase signaling axisCellular Signalling, 2019
- Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome―A consensus report from the Pulmonary Council of the ISHLTThe Journal of Heart and Lung Transplantation, 2019
- Humoral Human Lung Allograft Rejection by Tissue-Restricted Non-HLA AntibodiesThe Annals of Thoracic Surgery, 2016
- Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung TransplantationThe Journal of Heart and Lung Transplantation, 2016
- Progress in the biological function of alpha-enolaseAnimal Nutrition, 2016
- Type V Collagen2016
- Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allograftsThe Journal of Heart and Lung Transplantation, 2011
- Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathyThe Journal of Heart and Lung Transplantation, 2010
- Anti-MICA Antibodies Are Related to Adverse Outcome in Heart Transplant RecipientsThe Journal of Heart and Lung Transplantation, 2009